R. E. Stevens, V. Gray, A. Dorantes, L. Gold, and L. Pham, Scientific and Regulatory Standards for Assessing Product Performance Using the Similarity Factor, f2., AAPS Journal, 2015.

V. Gray, E. Cole, J. Toma, L. Ghidorsi, J. Guo, J Han, F. Han, C. Hosty, J.Kochling, J. Kraemer, T. Langdon, S. Leinbach, G. Martin, S. Meyerhoffer, R. Moreton, K. Raghavan, E. Shneyvas, J. Suggett, S. Tindal, M. Vudathala, H. Wang, O. Anand, Z. Gao, R. Shah, L. Xia, J. Fotso, M. Hussain, V. Schmidt, T. Ghosh, N. Davydova, W. Brown, J. Fringer, E. Stippler, T. Eranui, M. Marques, Use of Enzymes in the Dissolution Testing of Gelatin Capsules and Gelatin-Coated Tablets — Revisions to Dissolution <711> and Disintegration and Dissolution of Dietary Supplements <2040>, USP Pharmacopeial Forum 40 (6) November 2014 and Dissolution Technologies, 2014, 21(4), 6-9.

R. Skwierczynski, P. Curry, V. Gray, J. Kraemer, E. Stippler, J. Suggett, T. Mirza, and W. Brown, Revision of the Dissolution Procedure: Development and Validation <1092>, Dissolution Technologies, 2014, Vol. 21 (1), 6-12.

Vivian Gray and Tom Rosanske, Dissolution, Chapter 12 in the book titled, Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Edited by Christopher M. Riley, Thomas W. Rosanske and Shelley R. Rabel Riley, published by Elsevier, 2014; pp 245–263.

N. Fotaki, W. Brown, J. Kochling, Hitesh Chokshi, Mai Miao, Kin Tang, and V. Gray, Rational for Selection of Dissolution Media: Three Case Studies, Dissolution Technologies, 2013, Vol. 20 (3), 6-13.

G. Martin and V. Gray, General Considerations for Dissolution Methods: Development, Validation, and Transfer, JVT, 2011, Vol. 17, Number 1, 8-11.

G. Martin and V. Gray, Selection of Dissolution medium for QC Testing of Drug Products, GXP, 2011, Vol. 15, Number 4, 29-34.

G. Martin and V. Gray, Potential Pitfalls when Performing Dissolution Instrument Qualification, GXP, 2011, Vol. 15, Number 1, 6-12.

S. D’Souza, R. Lozano, S. Mayock, V. Gray, AAPS Workshop on the Role of Dissolution in QBD and Drug Product Life Cycle: A Commentary, Dissolution Technologies, 2010, Vol. 17 (4), 41-45

G. Martin and V. Gray, Dissolution Instrument Qualification, JVT, 2010, Vol. 16, Number 4, 10-16.

M. Marques, E. Cole, D. Kruep, V. Gray, D. Murachanian, W. Brown, G. Giancaspro, Liquid-filled Gelatin Capsules, Pharmacopeial Forum, 2009, Vol. 35 (4), 1029-1041

V. Gray, T. Mirza, R. Lozano, C. Tong, R. Löebenberg, B. Nickerson, Q. Wang, Role of Dissolution in Drug Development Continuum, Pharmaceutical Technologies, April , 2009.

V. Gray, G. Kelly, M. Xia, C. Butler, S. Thomas, S. Mayock, Expert Review- The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance, Pharm. Research, on-line Jan. 2009, http://www.springerlink.com/content/4863020493817088/fulltext.pdf., Spring 2009.

Vivian Gray, Jack Zheng, and Norman Sesi, In Vitro Dissolution and Method Development, chapter in the book titled, Formulation and Analytical Development for Low-Dose Oral Drug Products. Edited by Jack Zheng, published by John Wiley and Sons, Hoboken, NJ, 2009. ISBN: 978047005609.

Vivian Gray, Dissolution and Drug Release Testing, chapter in the book titled, Pharmaceutical Dosage Forms: Tablets, Third Edition, Volume 3: Manufacture and Process Control. Edited by Larry Augsburger and Stephen Hoag, published by Informa Healthcare, New York, NY, 2008. ISBN: 9780849390166.

V. A. Gray, A.J. Hickey, et al, The Inhalation Ad Hoc Panel for the USP Performance Tests of Inhalation Dosage Forms, Pharmacopeial Forum, 2008, 34 (4), 1068-1074.

Palmieri, A.; Gray, V. Dissolution of Heterogeneous Dosage Forms. In Dissolution Theory, Methodology, and Testing; Palmieri, A., Ed. Dissolution Technologies: Hockessin, DE, 2007. ISBN 0-9761519-1-X.

Martinez, M. N.; Bonate, P.; Chapman, R. L.; De Groot, A.; D’Souza, S.; Ghilazi, N.; Gray, V.; Gupta, V. K.; Huynh-Ba, K.; Iyer, S.; Jayatilaka, A.; Joshi, A.; Karnes, H. T.; Khan, M.; Liu, P.; Lunte, C.; McCurdy, C. R.; Morris, M. E.; Norris, K. J.; Ramsey, P.; Sehgal, S.; Zahn, M. 2007 Highlights of Advances in the Pharmaceutical Sciences: An American Association of Pharmaceutical Scientists (AAPS) Perspective. The AAPS J. 2007, 9 (2), Article 24.

Gray, V. A. Challenges to the Dissolution Test, Including Equipment Calibration. Pharm. Technol. 2006, Analytical Methods Primer, 4–13. Subsequently republished in Dissolution Technol. 2006, 13 (2), 6–9 and Pharm. Canada 2006, 7 (2), 13–16.

Hanson, R.; Gray, V. A. Handbook for Dissolution Testing, 3rd ed.; Dissolution Technologies, Inc.: Hockessin, DE, 2004.

Gray, V. A. Controlled Release Society Annual Meeting Report: Dissolution Highlights. Dissolution Technol. 2004, 11 (4), 30–31.

Gray, V. A. Future Directions for Dissolution Testing in the Pharmaceutical Industry. Dissolution Technol. 2004, 11 (3), 13–14.

Taborsky, C. J.; Gray, V. A. Meeting Report: AAPS/USP/CRS Workshop on Dissolution; New Technology and Regulatory Initiative. Dissolution Technol. 2004, 11 (2), 20–27.

Gray, V. A. Dissolution Specifications Industry Update. GMP Review, April 2004, 24–28.

Mirza, T.; Gray, V. A. Meeting Report: Conference on Dissolution, Bioequivalence, and Bioavailability. Dissolution Technol. 2004, 11 (1), 25–28.

Wang, Q.; Gray, V. A. HPLC in Dissolution Testing. In Handbook of Pharmaceutical Analysis by HPLC; Ahuja, S., Dong, M., Eds.; Elsevier: London, UK, 2005; Vol. 6.

Gray, V. A. Dissolution Testing: An Overview and Summary of Recent Trends and Regulatory Activities. Tablets and Capsules 2003, 1 (1), 20–24.

Mauger, J.; Ballard, J.; Brockson, R.; De, S.; Gray, V.; Robinson, D. Intrinsic Dissolution Performance Testing of the USP Dissolution Apparatus 2 (Rotating Paddle) Using Modified Salicylic Acid Calibrator Tablets: Proof of Principal. Dissolution Technol. 2003, 10 (3), 6–15.

Gray, V. A. Dissolution Testing Using Fiber Optics—A Regulatory Perspective. American Pharmaceutical Review 2003, 6 (2), 26–30 and Dissolution Technol. 2003, 10 (4), 33–36.

Gray, V. A.; Ballard, J. Getting Ready to Purchase a Fiber Optics System. http://www.dissolutionsolutions.net/fiberoptics/article2.html March 2003.

Gray, V. A. Dissolution Testing—Good Manufacturing Practices. Eur. Pharm. Rev. 2003, 1, 58–61.

Gray, V. A. Compendial Testing Equipment: Calibration, Qualification, and Sources of Error. In Pharmaceutical Dissolution Testing; Dressman, J., Kramer, J., Eds.; Taylor and Francis Group: Boca Raton, FL, 2005.

Hofer, J.; Gray, V. A. Examination of Selection of Immediate Release Dissolution Acceptance Criteria. Pharm. Forum 2003, 29 (1) and Dissolution Technol. 2003, 10 (1), 16–20.

Gray, V. A. Let’s Talk About Fiber Optics. http://www.dissolutionsolutions.net/fiberoptics/article1.html September 2002.

Gray, V. A. Meeting Report: AAPS/FDA Workshop on Biopharmaceutics Classification System. Dissolution Technol. 2002, 9 (4), 19–21.

Gray, V. A. Meeting Report: AAPS/FDA Workshop on Dissolution/In Vitro Release Testing and Specifications for Special Dosage Forms. Dissolution Technol. 2002, 9 (4), 16–18.

Gray, V. A.; Miller, B. Current Good Manufacturing Practices in the Dissolution Laboratory. Pharm. Canada 2002, 3 (3).

Gray, V. A. Identifying Sources of Error and Variability in Dissolution Calibration and Sample Testing. Am. Pharm. Rev. 2002, 5 (2), 8–13.

Gray, V. A. Meeting Report: AAPS/FDA Workshop on Drug Product and Drug Substance Specifications—Dissolution Summary. Dissolution Technol. 2002, 9 (2), 11–12.

Gray, V. A. Update on Dissolution Testing—Recent Activities and Trends. Dissolution Technol. 2002, 9 (1), 13–17.

Gray, V. A.; Beggy, M.; Brockson, R.; Corrigan, N.; Mullen, J. A Comparison of Dissolution Results Using O-Ring versus Clipped Basket Shafts. Dissolution Technol. 2001, 8 (4), 8–11.

Gray, V. A.; Brown, C. K.; Dressman, J. B.; Leeson, L. J. A New General Chapter on Dissolution. Pharm. Forum 2001, 27 (6).

Gray, V. A. Dissolution—Current Activities and Trends. Pharm. Canada 2001, 2 (2) and Dissolution Technol. 2001, 8 (4), 8–11.

Gray, V. A. Basic Dissolution Testing. AAPS Short Course [CD-ROM] (Microsoft Power Point electronic format).

PhRMA Subcommittee on Dissolution Calibration: Brune, S.; Bucko, J.; Emr, S.; Gray, V. A.; Hippeli, K.; Kentrup, A.; Whiteman, D.; Loranger, M.; Oates, M. Dissolution Calibrator: Recommendations for Reduced Chemical Testing and Enhanced Mechanical Calibration. Pharm. Forum 2000, 26 (4), 1149–1166.

Aubry, A. F.; Sebastian, D.; Hobson, T.; Xu, J. Q.; Gray, V. A. In-Use Testing of Extemporaneously Prepared Suspension of New Non-Nucleoside Reversed Transcriptase Inhibitors In Support of Phase I Clinical Studies. J. Pharm. Biomed. Anal. 2000, 23, 535–542.

Gelatin Capsule Working Group. Collaborative Development of Two-Tier Dissolution Testing for Gelatin Capsules and Gelatin-Coated Tablets Using Enzyme-Containing Media. Pharm. Forum 1998, 24 (5), 7045–7050.

Gray, V. A. Two-Tier Dissolution Testing. Dissolution Technol. 1998, 5 (2), 5–6.

Gray, V. A. Report on the USP Dissolution and Bioavailability Subcommittee Activity Regarding the Peak Vessel. Roundtable Conference Report: The Importance of Hydronamics in Dissolution Testing. Dissolution Technol. 1998, 5 (1), 19–21.

Gray, V. A.; Foster, T. S. Utility of USP Salicylic Acid Calibrator Tablets. Pharm. Forum 1997, 23 (6).

Gray, V. A.; Grady, L. T. USP Dissolution Standards—Revisions, Initiatives, and New Policies since 1980. Pharm Forum 1997, 23 (3), 4183–4197.

Okeke, C. C.; Barletta, F. P.; Gray, V. A.; Krasowski, J. A.; Paul, W. L.; Belson, J. J.; Grady, L. T. USP Standards and Activities Affecting Pharmacy Practice. Am. J. Health-Syst. Pharm. 1997, 54 (14), 1633-1638.

Foster, T. S.; Gray, V. A. USP Dissolution <711>, Pooled Sampling—Response to Comments Received. Pharm. Forum 1997, 23 (3), 4248–4249.

Gray, V. A.; Rippere, R. A. Labeling Issues for Recently Approved Abbreviated New Drug Applications for Extended-Release Products. Pharm. Forum 1996, 22 (1), 1942.

Gray, V. A.; Dressman, J. B. Change of pH Requirements for Simulated Intestinal Fluid TS. Pharm. Forum 1996, 22 (1), 1943–1945.

Gray, V. A.; Lovering, E. G. Other Impurities Proposal—The 0.1% Level in Foreign Substances and Impurities. Pharm. Forum 1995, 21 (6), 1650–1653.

Achanta, A. S.; Gray, V. A.; Cecil, T. L.; Grady, L. T. Evaluation of the Performance of Prednisone and Salicylic Acid USP Dissolution Calibrators. Drug Development and Industrial Pharmacy 1995, 21 (10), 1171–1182.

Gray, V. A.; Hubert, B. B.; Krasowski, J. A. Calibration of Dissolution Apparatus 1 and 2—What to Do When Your Equipment Fails. Pharm. Forum 1994, 20 (6), 8571–8573.

Taborsky-Urdinola, C. J.; Gray, V. A.; Grady, L. T. Effects of Packaging and Storage on the Dissolution of Model Prednisone Tablets. J. Hosp. Pharm. 1981, 38, 1322–1327.

Thakker, K. D.; Naik, N. C.; Gray, V. A.; Sun, S. Fine-Tuning of Dissolution Apparatus for Apparatus Suitability Test Using the USP Dissolution Calibrators. Pharm. Forum 1980, 6 (4).

Copyright 2004. Property of V. A. Gray Consulting, Inc. All Rights Reserved.